Skip to main content
Clinical Trials/NCT00197405
NCT00197405UnknownNot Applicable

Comparative Study of Fecal RNA Test With Immunochemical Fecal Occult Blood Test for Detecting Colorectal Cancer and Adenoma

Hamamatsu University1 site in 1 country400 target enrollmentStarted: August 1999Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
400
Locations
1

Study Overview

Brief Summary

Colorectal cancer (CRC) is the second common cause of death in the Western world, and is very increasing in Japan. Fecal occult blood test (FOBT) is used routinely for CRC screening, which has been shown to reduce the incidence, morbidity, and mortality of CRC. However, there is a need to develop a novel method to improve sensitivity. The investigators reported that Fecal COX-2 assay, one of fecal RNA test, is potentially useful for colorectal cancer screening (Gastroenterology 127; 422-427, 2004). So the investigators planed to compare fecal RNA test with FOBT for detecting colorectal cancer and adenoma.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Clinical diagnosis of colorectal cancer or adenoma
  • Subjects with no abnormal findings of colon

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Hamamatsu University
Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials

Comparison of Fecal Ribonucleic Acid (RNA)... | Clinical Trial